NANOBIOTIX NBTX
SPONSORED ADS · ADR · CUSIP 63009J107
- SectorHealth care
- IndustryPharmaceutical Preparations
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $5.00.
Trends to Q2 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 6 |
| Q4 2022 | 6 |
| Q1 2023 | 5 |
| Q2 2023 | 6 |
| Q3 2023 | 11 |
| Q4 2023 | 13 |
| Q1 2024 | 13 |
| Q2 2024 | 13 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 1 | 0 |
| Q1 2023 | 0 | 2 |
| Q2 2023 | 2 | 0 |
| Q3 2023 | 7 | 3 |
| Q4 2023 | 6 | 6 |
| Q1 2024 | 5 | 3 |
| Q2 2024 | 4 | 4 |
Biggest buyers
| GAMMA Investing LLC | Added | +880 |
| BANK OF AMERICA CORP /DE/ | Added | +498 |
| ROYAL BANK OF CANADA | Added | +229 |
| BARCLAYS PLC | New | +110 |
Biggest sellers
| BlackRock Inc. | Reduced | -14.4k |
| Tower Research Capital LLC (TRC) | Sold out | -450 |
| Qube Research & Technologies Ltd | Reduced | -276 |
| MORGAN STANLEY | Reduced | -4 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Invus Global Management, LLC 13G · passive investor +0.5 pts · filed 2026-08-13 | 9.4% |
| Qatar Investment Authority 13G · passive investor filed 2026-07-29 | 7.0% |
Insider purchases and sales in Q2 2024
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2024.
Holders, Q2 2024
| Manager | Shares | Change |
|---|---|---|
| JOHNSON & JOHNSON 7.02% of their portfolio | 5.6m $28.1m | Unchanged |
| BAILLIE GIFFORD & CO 0.01% of their portfolio | 2.9m $14.3m | Unchanged |
| PERCEPTIVE ADVISORS LLC 0.07% of their portfolio | 555.1k $2.8m | Unchanged |
| BlackRock Inc. 0.00% of their portfolio | 239.0k $1.2m | Reduced -14.4k |
| UBS Group AG 0.00% of their portfolio | 3.1k $15.5k | Unchanged |
| GAMMA Investing LLC 0.00% of their portfolio | 2.0k $10.2k | Added +880 |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 760 $3.8k | Added +498 |
| Qube Research & Technologies Ltd 0.00% of their portfolio | 343 $1.7k | Reduced -276 |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 263 $1.0k | Added +229 |
| BARCLAYS PLC 0.00% of their portfolio | 110 $550 | New |
| RHUMBLINE ADVISERS 0.00% of their portfolio | 33 $165 | Unchanged |
| MORGAN STANLEY 0.00% of their portfolio | 2 $10 | Reduced -4 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |